NGL Fine Chem Ltd.
| BSE: 524774 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE887E01022 |
| BSE 15:40 | 19 Apr | 1686.00 |
10.30 (0.61%) |
OPEN
1757.95 |
HIGH
1757.95 |
LOW
1625.10 |
| NSE 05:30 | 01 Jan | NGL Fine Chem Ltd |
| OPEN | 1757.95 |
| PREVIOUS CLOSE | 1675.70 |
| VOLUME | 1498 |
| 52-Week high | 1784.90 |
| 52-Week low | 300.00 |
| P/E | 25.22 |
| Mkt Cap.(Rs cr) | 1,042 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
NGL Fine Chem Ltd. (NGLFINECHEM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 971.15 | 18.15 | 1.90 | 13266.48 |
| Cipla | 946.60 | 7.90 | 0.84 | 12659.15 |
| Sun Pharma.Inds. | 640.00 | -6.05 | -0.94 | 12531.93 |
| Dr Reddy's Labs | 4970.55 | 77.55 | 1.58 | 11850.40 |
| Lupin | 1072.60 | 16.75 | 1.59 | 11025.66 |
| Apollo Hospitals | 3152.90 | 92.70 | 3.03 | 9794.50 |
| Glenmark Pharma. | 578.95 | 7.05 | 1.23 | 6712.63 |
| Alkem Lab | 2751.40 | -39.05 | -1.40 | 6677.08 |
| Cadila Health. | 527.30 | 0.30 | 0.06 | 6347.40 |
| Torrent Pharma. | 2593.60 | -25.55 | -0.98 | 6168.44 |
| Divi's Lab. | 3796.00 | -27.70 | -0.72 | 5310.57 |
| Ipca Labs. | 2167.00 | 23.80 | 1.11 | 4337.82 |
| Piramal Enterp. | 1651.00 | -68.50 | -3.98 | 4219.19 |
| Alembic Pharma | 1000.60 | 0.00 | 0.00 | 4132.55 |
| Abbott India | 14640.00 | -322.95 | -2.16 | 4093.14 |
| Glaxosmi. Pharma | 1423.00 | -46.60 | -3.17 | 3224.68 |
| Jubilant Pharmo | 770.70 | 46.60 | 6.44 | 3139.90 |
| Sanofi India | 7764.90 | -285.80 | -3.55 | 2901.10 |
| Laurus Labs | 440.75 | -5.40 | -1.21 | 2797.34 |
| Gland Pharma | 2733.00 | 103.90 | 3.95 | 2633.24 |
Quick Links for NGL Fine Chem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
